Polyuria resident survival guide: Difference between revisions
Jump to navigation
Jump to search
/* Common causes {{cite journal| author=Wieliczko M, Matuszkiewicz-Rowińska J| title=[Polyuria]. | journal=Wiad Lek | year= 2013 | volume= 66 | issue= 4 | pages= 324-8 | pmid=24490488 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24490488 }} {{cite journal| author=Weiss JP, Everaert K| title=Management of Nocturia and Nocturnal Polyuria. | journal=Urology | year= 2019 | volume= 133S | issue= | pag... |
|||
Line 36: | Line 36: | ||
**Drinking alcohol or caffeine | **Drinking alcohol or caffeine | ||
== | ==Management== | ||
*'''Diagnostic Approach''' | |||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 64: | Line 67: | ||
{{Family tree |,|^|-|-|-|.| | | }} | {{Family tree |,|^|-|-|-|.| | | }} | ||
{{Family tree | K01 | | K02 | | | | | | | |K01=(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin):<br>'''Complete Central DI'''| K02=(Urine osmolality <300 mOsm/kg or <50% increase):<br>'''Complete Nephrogenic DI'''}} | {{Family tree | K01 | | K02 | | | | | | | |K01=(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin):<br>'''Complete Central DI'''| K02=(Urine osmolality <300 mOsm/kg or <50% increase):<br>'''Complete Nephrogenic DI'''}} | ||
{{Family tree/end}} | |||
{{familytree/start |summary=polyuria diagnosis Algorithm.}} | |||
{{familytree | | | | | | | | A01 |A01='''Polyuria'''<br> ❑ 24-hour urine volume >'''3'''L <br> ❑ 24-hour urine volume >50 ml/kg}} | |||
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | |||
{{familytree | | | B01 | | | | | | | | B02 | | |B01='''Urine Osmolality >300'''mosmol|B02='''Urine Osmolality <300<ref>Robertson GL: Diabetes insipidus. Endocrinol Metab Clin North Am 24:549–572, 1995.</ref>'''mosmol}} | |||
{{familytree | | | |!| | | | | | | | | |!| }} | |||
{{familytree | | | C01 | | | | | | | | |!| |C01='''Solute diuresis'''<br> ❑ [[Glucose]] <br> ❑ [[Mannitol]] <br> ❑ [[Contrast media]] <br> ❑ [[High protein intake]] <br> ❑ [[Diuretics]] <br> ❑ [[Medullary cystic disease]] <br> ❑ [[Resolving ATN]] <br> ❑ [[Resolving obstruction]] }} | |||
{{familytree | | | | | | | | | | | | | |!| }} | |||
{{familytree | | | | | | | | | | | | | D03 |D03='''Water diuresis'''<br> ❑ [[Primary polydipsia]] <br> ❑ [[Diabetes inspidous]]}} | |||
{{familytree | | | | | | | | | | | | | |!| | }} | |||
{{familytree | | | | | | | | | | | | | E02 | | |E02=Water restriction test '''OR''' administration of hypertonic saline 0.05 mL/kg/min for 2 h|}} | |||
{{familytree | | | | | | | | | | | | | |!| | | }} | |||
{{familytree | | | | | | | | | | | | | F01 | | | |F01='''Water restriction test''' | |||
<br> ❑ Overnight fluid restriction should be '''avoided''' <br> ❑ Recommend the patient to stop drinking 2-3 hours before coming to clinic <br> ❑ Meaure urine volume every hour <br> ❑ Measure urine osmolality every hour <br> ❑ Measure plasma sodium concentration every 2 hours <br> ❑ Measure plasma osmolality every 2 hours |F02=F02}} | |||
{{familytree | | | | | | | | | | | | | |!| }} | |||
{{familytree | | | | | | | | | | | | | G01 |G01='''Test endpoints in adults:''' <br> ❑ Urine osmolality reaches normal value (above 600 mosmol/kg)[means that ADH release and effect are intact] <br> ❑ The urine osmolality is stable for 2 or 3 successive hourly measurements despite a rising plasma osmolality <br> ❑ Plasma osmolality >295-300 mosmol/kg <br> ❑ Plasma sodium is 145 or higher |}} | |||
{{familytree | | | | | | | | | | | | | |!| | | }} | |||
{{familytree | | | | | | | | | | | | | H01 |H01=In the last 3 settings '''[[desmopressin]] 10mcg intranasal''', or 4mcg SC/IV is administered <br> ❑ Measure urine volume and urine osmolality every 30 minutes over the next two hours|}} | |||
{{familytree | | | | | | | | | |,|-|-|-|+|-|-|-|.|}} | |||
{{familytree | | | | | | | | |I01 | |I02 | | |I03|I01=>100% rise in urine osmolality|I02=15-50% rise in urine osmolality after administration of exogenous [[desmopressin]]|I03=<15% rise in urine osmolality}} | |||
{{familytree | | | | | | | | | |!| | | |!| | | |!|}} | |||
{{familytree | | | | | | | | |J01 | |J02 | | |J03|J01='''Complete central diabetes inspidous'''<ref>Zerbe RL, Robertson GL: A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. The New England journal of medicine 1981, 305(26):1539-1546.</ref>|J02='''Partial central DI''' or '''partial nephrogenic DI'''<ref>Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH: Recognition of partial defects in antidiuretic hormone secretion. Annals of internal medicine 1970, 73(5):721-729.</ref>|J03='''complete nephrogenic DI''' or [['''primary polydipsia''']]|}} | |||
{{familytree | | | | | | | | | | | | | |!| }} | |||
{{familytree | | | | | | | | | | | | | K01 |K01=Check plasma and urine [[ADH]]<ref>Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bahr V, Oelkers W: Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical endocrinology 2001, 54(5):665-671.</ref>and [[copeptin]] prior to administration of exogenous ADH <br> ❑ Increase in plasma/urine [[ADH]] in response to rising plasma osmolality '''excludes''' [[central DI]] <br> ❑ Appropriate elevation in [[urine osmolality]] as [[ADH]] secretion is increased '''excludes''' nephrogenic DI <br> ❑ '''[[Copeptin]] > 21.4''' picomol/L differentiates Nephrogenic DI from other etiologies with 100% sensivity and specifity<ref> Timper K, Fenske W, Kuhn F, Frech N, Arici B, Rutishauser J, Kopp P, Allolio B, Stettler C, Muller B et al: Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. The Journal of clinical endocrinology and metabolism 2015, 100(6):2268-2274.</ref>|}} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
Revision as of 13:47, 25 September 2020
Overview
- Polyuria is defined as urine output more than 2 L/24 hours, or 30 ml/kg/24 hours. There are 3 pathophysiologic causes of polyuria: increased thirst (idiopathic, psychogenic polydepsia, hypothalamic disease, and medications), central diabetes insipidus (DI) (decreased secretion of arginine vasopressin (AVP)), and nephrogenic diabetes insipidus (DI) (renal resistance to AVP).[1]
- Nocturnal polyuria (NP), characterized by overproduction of urine at night (more than 20%-33% of total 24-hour urine volume depending on age). It can be caused by intake, urological, nephrological, hormonal, sleep, and cardiovascular factors. [2]
Causes
Life Threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Polyuria does not have life threatening causes.
Common causes [3] [2]
- The most common causes of polyuria are:
- Pregnancy
- Psychogenic polydipsia
- Central diabetes insipidus (CDI)
- Nephrogenic diabetes insipidus (NDI)
- Diabetes mellitus (DM)
- Chronic kidney disease (CKD)
- Urinary tract infection (UTI)
- Interstitial cystitis
- Nephrolithiasis
- Primary hyperparathyroidism
- Familial hypocalciuric hypercalcemia
- Hypercalcemia
- Hypokalemia
- Sickle cell disease (SCD)
- Stroke or neurological diseases
- Benign prostatic hyperplasia (BPH)
- Stress incontinence
- Medications:
- Overactive bladder
- Drinking alcohol or caffeine
Management
- Diagnostic Approach
Suspected hypotonic polyuria[4] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirm presence of polyuria: (>50ml/kg/24hrs or >3-4L/day) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Polyuria confirmed): Measure urine osmolality | (No polyuria/ or >800 mOsm/kg): Diabetes insipidus(DI)/Primary polydipsia ruled out | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(<800 mOsm/kg): Hypotonic polyuria confirmed: Measure serum Sodium and plasma osmolality | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low normal or low serum Sodium (<150 mmol/L), plasma osmolality (<280 mOsm/kg): Primary polydipsia | Normal serum Sodium/plasma osmolality: Indeterminate diagnosis | High serum Sodium (>146 mmol/L), plasma osmolality (>300 mOsm/kg): Central or Nephrogenic DI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Water deprivation test | Baseline plasma copeptin | Hypertonic saline infusion test | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Urine Osm >800 mOsm/kg | Urine Osm <300 mOsm/kg | Urine Osm 300-800 mOsm/kg | Plasma coprptin >4.9pmol/L | Plasma coprptin <4.9pmol/L | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild primary polyuria | Desmopressin administration | >21pmol/L | <2.6pmol/L | >2.6pmol/L | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(Urine Osmolality: 300-800 mOsm/Kg and <50% increase): Therapeutic trial with desmopressin | Nephrogenic DI(partial or complete) | Complete Central DI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary polydipsia | Partial Nephrogenic DI | Partial Central DI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Initial urine osmolality: 30 mOsm/kg and >50% increase after desmopressin): Complete Central DI | (Urine osmolality <300 mOsm/kg or <50% increase): Complete Nephrogenic DI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Polyuria ❑ 24-hour urine volume >3L ❑ 24-hour urine volume >50 ml/kg | |||||||||||||||||||||||||||||||||||||||||
Urine Osmolality >300mosmol | Urine Osmolality <300[5]mosmol | ||||||||||||||||||||||||||||||||||||||||
Solute diuresis ❑ Glucose ❑ Mannitol ❑ Contrast media ❑ High protein intake ❑ Diuretics ❑ Medullary cystic disease ❑ Resolving ATN ❑ Resolving obstruction | |||||||||||||||||||||||||||||||||||||||||
Water diuresis ❑ Primary polydipsia ❑ Diabetes inspidous | |||||||||||||||||||||||||||||||||||||||||
Water restriction test OR administration of hypertonic saline 0.05 mL/kg/min for 2 h | |||||||||||||||||||||||||||||||||||||||||
Water restriction test
❑ Overnight fluid restriction should be avoided ❑ Recommend the patient to stop drinking 2-3 hours before coming to clinic ❑ Meaure urine volume every hour ❑ Measure urine osmolality every hour ❑ Measure plasma sodium concentration every 2 hours ❑ Measure plasma osmolality every 2 hours | |||||||||||||||||||||||||||||||||||||||||
Test endpoints in adults: ❑ Urine osmolality reaches normal value (above 600 mosmol/kg)[means that ADH release and effect are intact] ❑ The urine osmolality is stable for 2 or 3 successive hourly measurements despite a rising plasma osmolality ❑ Plasma osmolality >295-300 mosmol/kg ❑ Plasma sodium is 145 or higher | |||||||||||||||||||||||||||||||||||||||||
In the last 3 settings desmopressin 10mcg intranasal, or 4mcg SC/IV is administered ❑ Measure urine volume and urine osmolality every 30 minutes over the next two hours | |||||||||||||||||||||||||||||||||||||||||
>100% rise in urine osmolality | 15-50% rise in urine osmolality after administration of exogenous desmopressin | <15% rise in urine osmolality | |||||||||||||||||||||||||||||||||||||||
Complete central diabetes inspidous[6] | Partial central DI or partial nephrogenic DI[7] | complete nephrogenic DI or '''primary polydipsia''' | |||||||||||||||||||||||||||||||||||||||
Check plasma and urine ADH[8]and copeptin prior to administration of exogenous ADH ❑ Increase in plasma/urine ADH in response to rising plasma osmolality excludes central DI ❑ Appropriate elevation in urine osmolality as ADH secretion is increased excludes nephrogenic DI ❑ Copeptin > 21.4 picomol/L differentiates Nephrogenic DI from other etiologies with 100% sensivity and specifity[9] | |||||||||||||||||||||||||||||||||||||||||
Do's
Don'ts
References
- ↑ Moore K, Thompson C, Trainer P (2003). "Disorders of water balance". Clin Med (Lond). 3 (1): 28–33. doi:10.7861/clinmedicine.3-1-28. PMC 4953350. PMID 12617410.
- ↑ 2.0 2.1 Weiss JP, Everaert K (2019). "Management of Nocturia and Nocturnal Polyuria". Urology. 133S: 24–33. doi:10.1016/j.urology.2019.09.022. PMID 31586470.
- ↑ Wieliczko M, Matuszkiewicz-Rowińska J (2013). "[Polyuria]". Wiad Lek. 66 (4): 324–8. PMID 24490488.
- ↑ Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K; et al. (2000). "Endotext". PMID 30779536.
- ↑ Robertson GL: Diabetes insipidus. Endocrinol Metab Clin North Am 24:549–572, 1995.
- ↑ Zerbe RL, Robertson GL: A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. The New England journal of medicine 1981, 305(26):1539-1546.
- ↑ Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH: Recognition of partial defects in antidiuretic hormone secretion. Annals of internal medicine 1970, 73(5):721-729.
- ↑ Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bahr V, Oelkers W: Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical endocrinology 2001, 54(5):665-671.
- ↑ Timper K, Fenske W, Kuhn F, Frech N, Arici B, Rutishauser J, Kopp P, Allolio B, Stettler C, Muller B et al: Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. The Journal of clinical endocrinology and metabolism 2015, 100(6):2268-2274.